Defense World
02 Jan 2026, 09:27 UTC · 39w ago
Atul Dandekar Sells 72,400 Shares of Maze Therapeutics (NASDAQ:MAZE) Stock
Verdict
Headline takes no side. We score MAZE −0.20 — slightly bearish.
- Expected · MAZE
−0.20slightly bearish
−1 bearish0bullish +1More negative than 64% of ticker scores this week
- Actual
Scored by the NIS engine · methodology.

Search tags




